(CHE) Chemed - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US16359R1032
CHE: Healthcare, Plumbing, Hospice, Palliative, Counseling, Restoration
Chemed Corporation (NYSE:CHE) operates two distinct business segments: VITAS Healthcare and Roto-Rooter. VITAS Healthcare is a leading provider of end-of-life care, offering hospice and palliative services to patients across the United States. This segment delivers comprehensive care through a multidisciplinary team of physicians, nurses, social workers, chaplains, and volunteers, ensuring patients and their families receive medical, emotional, and spiritual support. The Roto-Rooter segment provides essential plumbing, drain cleaning, excavation, water restoration, and related services to residential and commercial customers. This segment utilizes a network of company-owned branches, independent contractors, and franchisees to maintain its market presence.
Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio. The company has established itself as a key player in both healthcare services and plumbing solutions, with a strong operational footprint across the U.S. Its dual-segment business model allows for diversification, balancing the stable demand for hospice care with the cyclical nature of plumbing services. Web URL: https://www.chemed.com
3-Month Forecast: Based on
Additional Sources for CHE Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CHE Stock Overview
Market Cap in USD | 8,122m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 1973-05-03 |
CHE Stock Ratings
Growth Rating | 44.4 |
Fundamental | 83.8 |
Dividend Rating | 53.5 |
Rel. Strength | 2.97 |
Analysts | 4.67/5 |
Fair Price Momentum | 555.12 USD |
Fair Price DCF | 657.24 USD |
CHE Dividends
Dividend Yield 12m | 0.33% |
Yield on Cost 5y | 0.46% |
Annual Growth 5y | 6.40% |
Payout Consistency | 97.0% |
CHE Growth Ratios
Growth Correlation 3m | 36.6% |
Growth Correlation 12m | 28.5% |
Growth Correlation 5y | 79% |
CAGR 5y | 6.96% |
CAGR/Max DD 5y | 0.26 |
Sharpe Ratio 12m | 0.57 |
Alpha | -4.04 |
Beta | 0.174 |
Volatility | 21.83% |
Current Volume | 113.8k |
Average Volume 20d | 124.1k |
As of May 02, 2025, the stock is trading at USD 573.74 with a total of 113,752 shares traded.
Over the past week, the price has changed by +4.93%, over one month by -7.25%, over three months by +3.43% and over the past year by +1.70%.
Yes, based on ValueRay Fundamental Analyses, Chemed (NYSE:CHE) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 83.78 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CHE as of May 2025 is 555.12. This means that CHE is currently overvalued and has a potential downside of -3.25%.
Chemed has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy CHE.
- Strong Buy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CHE Chemed will be worth about 601.5 in May 2026. The stock is currently trading at 573.74. This means that the stock has a potential upside of +4.83%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 675 | 17.6% |
Analysts Target Price | 663.7 | 15.7% |
ValueRay Target Price | 601.5 | 4.8% |